Sage Therapeutics
SAGE
#7472
Rank
NZ$0.49 B
Marketcap
$8.11
Share price
-6.27%
Change (1 day)
-75.33%
Change (1 year)

Earnings for Sage Therapeutics (SAGE)

Earnings in 2024 (TTM): -NZ$0.55 Billion

According to Sage Therapeutics 's latest financial reports the company's current earnings are NZ$0.10 Billion. In 2023 the company made an earning of -NZ$0.92 Billion a decrease over its 2022 earnings that were of -NZ$0.91 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sage Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.55 Billion-40.19%
2023 -NZ$0.92 Billion1.63%
2022 -NZ$0.91 Billion16.36%
2021 -NZ$0.78 Billion-175.55%
2020 NZ$1.02 B-189.1%
2019 -NZ$1.16 Billion82.43%
2018 -NZ$0.64 Billion38.04%
2017 -NZ$0.46 Billion69.9%
2016 -NZ$0.27 Billion68.25%
2015 -NZ$0.17 Billion179.48%
2014 -NZ$57.39 Million84.98%
2013 -NZ$31.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$59.41 Million-89.63%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$60.52 M-110.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.86 B-251.82%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-NZ$98.46 Million-82.82%๐Ÿ‡บ๐Ÿ‡ธ USA